GLAXO's ETHAMOLIN AND OXISTAT ARE AMONG FDA's LATE DECEMBER APPROVALS; BRISTOL-MYERS IFOSFAMIDE, ASTA's MESNA & AMERSHAM's CERETEC ALSO CLEARED